Oragenics Inc.

AMEX: OGEN · Real-Time Price · USD
1.14
-0.05 (-4.20%)
At close: Aug 15, 2025, 3:59 PM
1.17
2.61%
After-hours: Aug 15, 2025, 07:37 PM EDT

Oragenics Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
n/a n/a n/a n/a n/a n/a -37.65K 7.47K 13.16K 17.02K 131.52K 86.05K 30.39K 15.08K 86.99K n/a n/a n/a
Cost of Revenue
n/a 341.54K 1.57M 879.04K 906.78K 663.41K 11.04M 4.79K 11.3K 11.3K 13.07K 12.75K 10.38K 8.47K 6.42K 9.64K 12.45K 12.72K
Gross Profit
n/a -341.54K 1.57M -879.04K -906.78K -663.41K -11.04M 2.68K 1.86K n/a 118.45K 73.3K 20.01K 6.62K 80.57K -9.64K -12.45K -12.72K
Operating Income
-1.71M -2.03M -3.35M -2.44M -2.31M -2.46M -12.8M -2.09M -3.11M -2.9M -360K -3.95M -3.6M -4.61M -2.3M -4.39M -3.84M -5.24M
Interest Income
16.79K 10.2K 10.79K 9.47K 6.41K 19.23K 38.63K 50.61K 58.95K 62.2K 66.99K 41.63K 15.37K 11.91K 13.8K 17.76K 24.25K 20.03K
Pretax Income
-2.27M -2.22M -3.35M -2.46M -2.31M -2.45M -12.75M -2.01M -3.05M -2.84M -2.24M -3.92M -4.03M -4.59M -2.29M -4.38M -3.81M -5.22M
Net Income
-2.27M -2.22M -3.35M -2.46M -2.31M -2.45M -12.75M -2.01M -3.05M -2.84M -303K -3.88M -4.03M -6.02M -2.29M -4.38M -3.81M -5.22M
Selling & General & Admin
1.26M 1.69M 1.69M 1.56M 1.4M 1.8M 1.75M 1.33M 1.12M 1.25M 883.57K 1.22M 1.04M 1.33M 1.08M 847.13K 1.37M 1.98M
Research & Development
449.68K 341.54K 1.67M 879.04K 906.78K 663.41K 768.48K 769.35K 2.01M 1.67M -523K 2.78M 3.03M 4.74M 1.31M 3.55M 2.47M 3.26M
Other Expenses
n/a -542 n/a -41 221.00 -414 525.00 -7.47K -13.16K -17.02K -3.67K n/a -29.9K -490 -1.2K -2 600.00 670.00
Operating Expenses
1.71M 2.03M 3.35M 2.44M 2.31M 2.46M 2.52M 2.09M 3.11M 2.9M 495.61K 3.95M 4.05M 4.61M 2.39M 4.39M 3.84M 5.24M
Interest Expense
572.31K 199.13K 10.97K 9.97K 1.8K 7.08K 12.23K 14.17K 843.00 3.35K 5.81K 5.23K 816.00 3.25K 5.1K 7.05K 1.03K 2.57K
Selling & Marketing Expenses
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses
1.71M 2.03M 3.35M 2.44M 2.31M 2.46M 2.52M 2.09M 3.11M 2.9M 490.47K 3.95M 4.05M 4.61M 2.39M 4.39M 3.84M 5.24M
Income Tax Expense
n/a n/a n/a n/a n/a -6.85K -4.12K n/a 1.46K n/a -57.76K -35.92K 1.19K -19.13K -8.54K -10.71K -22.62K -17.54K
Shares Outstanding (Basic)
7.32K 1.82K 6.62M 6.53M 4.53M 3.5M 2.59M 2.36M 2.02M 2.02M 2.21M 1.95M 1.94M 1.94M 1.91M 1.94M 1.93M 1.72M
Shares Outstanding (Diluted)
7.32K 1.82K 6.62M 6.53M 4.53M 3.5M 2.59M 2.36M 2.02M 2.02M 2.21M 1.95M 1.94M 1.94M 1.91M 1.94M 1.93M 1.72M
EPS (Basic)
-3.1 -1.22K -0.51 -0.38 -0.51 -0.7 -4.92 -0.85 -1.51 -1.41 -0.12 -1.99 -2.08 -3.1 -1.2 -2.26 -1.98 -3.04
EPS (Diluted)
-3.1 -1.22K -0.51 -0.38 -0.51 -0.7 -4.92 -0.85 -1.51 -1.41 -0.12 -1.99 -2.08 -3.1 -1.2 -2.26 -1.98 -3.04
EBITDA
-1.71M -2.02M -3.34M -2.45M -2.3M -2.44M -12.74M -1.99M -3.04M -2.83M -437K -3.85M -3.58M -4.58M -2.28M -4.37M -3.8M -5.21M
EBIT
-1.7M -2.02M -3.34M -2.45M -2.3M -2.44M -12.73M -2M -3.05M -2.84M -297K -3.86M -3.6M -4.59M -2.29M -4.38M -3.81M -5.22M
Depreciation & Amortization
n/a 2.03M 1.92K 6.85K 6.85K 6.85K n/a 4.79K 11.3K 11.3K 13.07K 12.75K 10.38K 8.47K 6.42K 9.64K 12.45K 12.72K